Contact Information
About
Fluicell AB leads in regenerative medicine and drug screening with its Nexocyte™ platform, offering precision-engineered biological tissues for treating diseases like type 1 diabetes. Unique for its single-cell bioprinting technology, Fluicell revolutionizes tissue solutions, enhancing drug development and therapeutic possibilities.
Is this your clinic? Upgrade your listing →

